Progenics Pharmaceuticals and 4 Sizzling Stocks Round Out the Week Stronger After Earnings

Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) had a loss and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.24 in the quarter versus EPS of $-0.32 in the year-earlier quarter. Revenue Decreased 1.1% to $1.8 million from the year-earlier quarter.

Progenics Pharmaceuticals Inc. reported adjusted EPS loss of $0.24 per share. By that measure, the company missed the mean analyst estimate of $-0.24. It missed the average revenue estimate of $1.86 million.

PGNX 20130811

ML NIKKEI225 MITTS09 (NYSE:MNK) delivered a profit and missed Wall Street’s expectations, BUT beat the revenue expectation. Revenue Decreased 0% to $570 million from the year-earlier quarter.

ML NIKKEI225 MITTS09 reported adjusted EPS income of $0.49 per share. By that measure, the company missed the mean analyst estimate of $0.79. It beat the average revenue estimate of $560.17 million.

MNK 20130811

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.36 in the quarter versus EPS of $-0.47 in the year-earlier quarter. Revenue Rose 32.81% to $3.4 million from the year-earlier quarter.

Anacor Pharmaceuticals, Inc. reported adjusted EPS loss of $0.36 per share. By that measure, the company beat the mean analyst estimate of $-0.39. It beat the average revenue estimate of $2.6 million.

ANAC 20130811

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.29 in the quarter versus EPS of $-0.25 in the year-earlier quarter. Revenue Decreased 58.33% to $8.7 million from the year-earlier quarter.

Alnylam Pharmaceuticals, Inc. reported adjusted EPS loss of $0.29 per share. By that measure, the company beat the mean analyst estimate of $-0.35. It missed the average revenue estimate of $8.99 million.

ALNY 20130811

Select Medical Holdings Corporation (NYSE:SEM) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 12.9% to $0.27 in the quarter versus EPS of $0.31 in the year-earlier quarter. Revenue Rose 0.87% to $756.7 million from the year-earlier quarter.

Select Medical Holdings Corporation reported adjusted EPS income of $0.27 per share. By that measure, the company beat the mean analyst estimate of $0.24. It beat the average revenue estimate of $752.84 million.

SEM 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , ,  

More from The Cheat Sheet